Drugs for Schistosomiasis Market in Southeast Asia - Manufacturing and Consumption, Outlook and Forecast 2020-2026

April 2020 | 91 pages | ID: D9864E04135BEN
Market Monitor Global

Abstracts

Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
This report contains market size and forecasts of Drugs for Schistosomiasis in Southeast Asia, including the following market information:
Southeast Asia Drugs for Schistosomiasis Market Revenue, 2015-2020, 2021-2026, ($ millions)
Southeast Asia Drugs for Schistosomiasis Market Consumption, 2015-2020, 2021-2026, (M Units)
Southeast Asia Drugs for Schistosomiasis Production Capacity, 2015-2020, 2021-2026, (M Units)
Top Five Competitors in Southeast Asia Drugs for Schistosomiasis Market 2019 (%)
The global Drugs for Schistosomiasis market was valued at 78 million in 2019 and is projected to reach US$ 90 million by 2026, at a CAGR of 3.6% during the forecast period. While the Drugs for Schistosomiasis market size in Southeast Asia was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs for Schistosomiasis manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Drugs for Schistosomiasis production and consumption in Southeast Asia

Total Market by Segment:

Southeast Asia Drugs for Schistosomiasis Market, By Type, 2015-2020, 2021-2026 ($ millions) & (M Units)
Southeast Asia Drugs for Schistosomiasis Market Segment Percentages, By Type, 2019 (%)

• Praziquantel
• Oxamniquine
• Other

Southeast Asia Drugs for Schistosomiasis Market, By Application, 2015-2020, 2021-2026 ($ millions) & (M Units)
Southeast Asia Drugs for Schistosomiasis Market Segment Percentages, By Application, 2019 (%)

• S. haematobium
• S. mansoni
• S. japonicum
• S. mekongi
• S. intercalatum

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Drugs for Schistosomiasis Market Competitors Revenues in Southeast Asia, by Players 2015-2020 (Estimated), ($ millions)
Total Drugs for Schistosomiasis Market Competitors Revenues Share in Southeast Asia, by Players 2019 (%)
Total Southeast Asia Drugs for Schistosomiasis Market Competitors Sales, by Players 2015-2020 (Estimated), (M Units)
Total Southeast Asia Drugs for Schistosomiasis Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:

• Shin Poong
• Merck
• Bayer
• EIPICO
• Chandra Bhagat Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Drugs for Schistosomiasis Market Definition
1.2 Market Segments
  1.2.1 Segment by Type
  1.2.2 Segment by Application
1.3 Southeast Asia Drugs for Schistosomiasis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 COVID-19 IMPACT: SOUTHEAST ASIA DRUGS FOR SCHISTOSOMIASIS OVERALL MARKET SIZE

2.1 Southeast Asia Drugs for Schistosomiasis Market Size: 2020 VS 2026
2.2 Southeast Asia Drugs for Schistosomiasis Revenue, Prospects & Forecasts: 2015-2026
2.3 Southeast Asia Drugs for Schistosomiasis Sales (Consumption): 2015-2026

3 COMPANY LANDSCAPE

3.1 Top Drugs for Schistosomiasis Players in Southeast Asia (including Foreign and Local Companies)
3.2 Top Southeast Asia Drugs for Schistosomiasis Companies Ranked by Revenue
3.3 Southeast Asia Drugs for Schistosomiasis Revenue by Companies (including Foreign and Local Companies)
3.4 Southeast Asia Drugs for Schistosomiasis Sales by Companies (including Foreign and Local Companies)
3.5 Southeast Asia Drugs for Schistosomiasis Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Drugs for Schistosomiasis Companies in Southeast Asia, by Revenue in 2019
3.7 Southeast Asia Manufacturers Drugs for Schistosomiasis Product Type
3.8 Tier 1, Tier 2 and Tier 3 Drugs for Schistosomiasis Players in Southeast Asia
  3.8.1 List of Southeast Asia Tier 1 Drugs for Schistosomiasis Companies
  3.8.2 List of Southeast Asia Tier 2 and Tier 3 Drugs for Schistosomiasis Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Southeast Asia Drugs for Schistosomiasis Market Size Markets, 2020 & 2026
  4.1.2 Praziquantel
  4.1.3 Oxamniquine
  4.1.4 Other
4.2 By Type - Southeast Asia Drugs for Schistosomiasis Revenue & Forecasts
  4.2.1 By Type - Southeast Asia Drugs for Schistosomiasis Revenue, 2015-2020
  4.2.2 By Type - Southeast Asia Drugs for Schistosomiasis Revenue, 2021-2026
  4.2.3 By Type - Southeast Asia Drugs for Schistosomiasis Revenue Market Share, 2015-2026
4.3 By Type - Southeast Asia Drugs for Schistosomiasis Sales & Forecasts
  4.3.1 By Type - Southeast Asia Drugs for Schistosomiasis Sales, 2015-2020
  4.3.2 By Type - Southeast Asia Drugs for Schistosomiasis Sales, 2021-2026
  4.3.3 By Type - Southeast Asia Drugs for Schistosomiasis Sales Market Share, 2015-2026
4.4 By Type - Southeast Asia Drugs for Schistosomiasis Price (Manufacturers Selling Prices), 2015-2026

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Southeast Asia Drugs for Schistosomiasis Market Size, 2020 & 2026
  5.1.2 S. haematobium
  5.1.3 S. mansoni
  5.1.4 S. japonicum
  5.1.5 S. mekongi
  5.1.6 S. intercalatum
5.2 By Application - Southeast Asia Drugs for Schistosomiasis Revenue & Forecasts
  5.2.1 By Application - Southeast Asia Drugs for Schistosomiasis Revenue, 2015-2020
  5.2.2 By Application - Southeast Asia Drugs for Schistosomiasis Revenue, 2021-2026
  5.2.3 By Application - Southeast Asia Drugs for Schistosomiasis Revenue Market Share, 2015-2026
5.3 By Application - Southeast Asia Drugs for Schistosomiasis Sales & Forecasts
  5.3.1 By Application - Southeast Asia Drugs for Schistosomiasis Sales, 2015-2020
  5.3.2 By Application - Southeast Asia Drugs for Schistosomiasis Sales, 2021-2026
  5.3.3 By Application - Southeast Asia Drugs for Schistosomiasis Sales Market Share, 2015-2026
5.4 By Application - Southeast Asia Drugs for Schistosomiasis Price (Manufacturers Selling Prices), 2015-2026

6 MANUFACTURERS & BRANDS PROFILES

6.1 Shin Poong
  6.1.1 Shin Poong Corporate Summary
  6.1.2 Shin Poong Business Overview
  6.1.3 Shin Poong Drugs for Schistosomiasis Major Product Offerings
  6.1.4 Shin Poong Sales and Revenue in Southeast Asia (2015-2020)
  6.1.5 Shin Poong Key News
6.2 Merck
  6.2.1 Merck Corporate Summary
  6.2.2 Merck Business Overview
  6.2.3 Merck Drugs for Schistosomiasis Major Product Offerings
  6.2.4 Merck Sales and Revenue in Southeast Asia (2015-2020)
  6.2.5 Merck Key News
6.3 Bayer
  6.3.1 Bayer Corporate Summary
  6.3.2 Bayer Business Overview
  6.3.3 Bayer Drugs for Schistosomiasis Major Product Offerings
  6.3.4 Bayer Sales and Revenue in Southeast Asia (2015-2020)
  6.3.5 Bayer Key News
6.4 EIPICO
  6.4.1 EIPICO Corporate Summary
  6.4.2 EIPICO Business Overview
  6.4.3 EIPICO Drugs for Schistosomiasis Major Product Offerings
  6.4.4 EIPICO Sales and Revenue in Southeast Asia (2015-2020)
  6.4.5 EIPICO Key News
6.5 Chandra Bhagat Pharma
  6.5.1 Chandra Bhagat Pharma Corporate Summary
  6.5.2 Chandra Bhagat Pharma Business Overview
  6.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Major Product Offerings
  6.5.4 Chandra Bhagat Pharma Sales and Revenue in Southeast Asia (2015-2020)
  6.5.5 Chandra Bhagat Pharma Key News
6.6 Taj Pharmaceuticals
  6.6.1 Taj Pharmaceuticals Corporate Summary
  6.6.2 Taj Pharmaceuticals Business Overview
  6.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Major Product Offerings
  6.6.4 Taj Pharmaceuticals Sales and Revenue in Southeast Asia (2015-2020)
  6.6.5 Taj Pharmaceuticals Key News

7 DRUGS FOR SCHISTOSOMIASIS PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS

7.1 Drugs for Schistosomiasis Production Capacity and Value in Southeast Asia, Situation Analysis and Prediction, 2015-2026
  7.1.1 Southeast Asia Drugs for Schistosomiasis Production Capacity, 2015-2026
  7.1.2 Southeast Asia Drugs for Schistosomiasis Production 2015-2026
  7.1.3 Southeast Asia Drugs for Schistosomiasis Production Value 2015-2026
7.2 Key Local Drugs for Schistosomiasis Manufacturers in Southeast Asia
  7.2.1 Southeast Asia Key Local Drugs for Schistosomiasis Manufacturers Production Capacity
  7.2.2 Southeast Asia Key Local Drugs for Schistosomiasis Manufacturers Production
  7.2.3 Southeast Asia Key Local Drugs for Schistosomiasis Manufacturers Production Value
  7.2.4 The Proportion of Drugs for Schistosomiasis Production Sold in Southeast Asia and Sold Other Than Southeast Asia by Manufacturers
7.3 Drugs for Schistosomiasis Export and Import in Southeast Asia
  7.3.1 Southeast Asia Drugs for Schistosomiasis Export Market
  7.3.2 Southeast Asia Drugs for Schistosomiasis Source of Imports

8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

8.1 PESTLE Analysis for Southeast Asia Drugs for Schistosomiasis Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 COVID-19 IMPACT ON DRUGS FOR SCHISTOSOMIASIS SUPPLY CHAIN ANALYSIS

9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
  9.4.1 Marketing Channels
  9.4.2 Drugs for Schistosomiasis Distributors and Sales Agents in Southeast Asia

10 CONCLUSION

11 APPENDIX

11.1 Note
11.2 Examples of Clients
11.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Drugs for Schistosomiasis in Southeast Asia
Table 2. Top Players in Southeast Asia, Ranking by Revenue (2019)
Table 3. Southeast Asia Drugs for Schistosomiasis Revenue by Companies, (US$, Mn), 2015-2020
Table 4. Southeast Asia Drugs for Schistosomiasis Revenue Share by Companies, 2015-2020
Table 5. Southeast Asia Drugs for Schistosomiasis Sales by Companies, (M Units), 2015-2020
Table 6. Southeast Asia Drugs for Schistosomiasis Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Drugs for Schistosomiasis Price (2015-2020) (USD/K Units)
Table 8. Southeast Asia Manufacturers Drugs for Schistosomiasis Product Type
Table 9. List of Southeast Asia Tier 1 Drugs for Schistosomiasis Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of Southeast Asia Tier 2 and Tier 3 Drugs for Schistosomiasis Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Drugs for Schistosomiasis Revenue in Southeast Asia (US$, Mn), 2015-2020
Table 12. By Type - Drugs for Schistosomiasis Revenue in Southeast Asia (US$, Mn), 2021-2026
Table 13. By Type - Drugs for Schistosomiasis Sales in Southeast Asia (M Units), 2015-2020
Table 14. By Type - Drugs for Schistosomiasis Sales in Southeast Asia (M Units), 2021-2026
Table 15. By Application - Drugs for Schistosomiasis Revenue in Southeast Asia, (US$, Mn), 2015-2020
Table 16. By Application - Drugs for Schistosomiasis Revenue in Southeast Asia, (US$, Mn), 2021-2026
Table 17. By Application - Drugs for Schistosomiasis Sales in Southeast Asia, (M Units), 2015-2020
Table 18. By Application - Drugs for Schistosomiasis Sales in Southeast Asia, (M Units), 2021-2026
Table 19. Shin Poong Corporate Summary
Table 20. Shin Poong Drugs for Schistosomiasis Product Offerings
Table 21. Shin Poong Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 22. Merck Corporate Summary
Table 23. Merck Drugs for Schistosomiasis Product Offerings
Table 24. Merck Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 25. Bayer Corporate Summary
Table 26. Bayer Drugs for Schistosomiasis Product Offerings
Table 27. Bayer Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 28. EIPICO Corporate Summary
Table 29. EIPICO Drugs for Schistosomiasis Product Offerings
Table 30. EIPICO Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 31. Chandra Bhagat Pharma Corporate Summary
Table 32. Chandra Bhagat Pharma Drugs for Schistosomiasis Product Offerings
Table 33. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 34. Taj Pharmaceuticals Corporate Summary
Table 35. Taj Pharmaceuticals Drugs for Schistosomiasis Product Offerings
Table 36. Taj Pharmaceuticals Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 37. Drugs for Schistosomiasis Production Capacity (M Units) of Local Manufacturers in Southeast Asia, 2015-2020
Table 38. Drugs for Schistosomiasis Production (M Units) of Local Manufacturers in Southeast Asia, 2015-2020
Table 39. Southeast Asia Drugs for Schistosomiasis Production Market Share of Local Manufacturers, 2015-2020
Table 40. Drugs for Schistosomiasis Production Value (US$, Mn) of Local Manufacturers in Southeast Asia, 2015-2020
Table 41. Southeast Asia Drugs for Schistosomiasis Production Value Market Share of Local Manufacturers, 2015-2020
Table 42. The Percentage of Drugs for Schistosomiasis Production Sold in Southeast Asia and Sold Other Than Southeast Asia by Manufacturers
Table 43. The Percentage of Drugs for Schistosomiasis Production Sold in Southeast Asia and Sold Other Than Southeast Asia by Manufacturers
Table 44. Dangeguojia Drugs for Schistosomiasis Sales (Consumption), Production, Export and Import, 2015-2020
Table 45. Raw Materials and Suppliers
Table 46. Drugs for Schistosomiasis Downstream Clients in Southeast Asia
Table 47. Drugs for Schistosomiasis Distributors and Sales Agents in Southeast Asia

List Of Figures

LIST OF FIGURES

Figure 1. Drugs for Schistosomiasis Segment by Type
Figure 2. Drugs for Schistosomiasis Segment by Application
Figure 3. Dangeguojia Drugs for Schistosomiasis Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Drugs for Schistosomiasis Market Size in Southeast Asia, (US$, Mn) & (M Units): 2020 VS 2026
Figure 6. Southeast Asia Drugs for Schistosomiasis Revenue, 2015-2026 (US$, Mn)
Figure 7. Drugs for Schistosomiasis Sales in Southeast Asia: 2015-2026 (M Units)
Figure 8. The Top 3 and 5 Players Market Share by Drugs for Schistosomiasis Revenue in 2019
Figure 9. By Type - Southeast Asia Drugs for Schistosomiasis Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - Southeast Asia Drugs for Schistosomiasis Market Share, 2015-2020
Figure 11. By Type - Southeast Asia Drugs for Schistosomiasis Market Share, 2020-2026
Figure 12. By Type - Southeast Asia Drugs for Schistosomiasis Price (USD/K Units), 2015-2026
Figure 13. By Application - Drugs for Schistosomiasis Revenue in Southeast Asia (US$, Mn), 2020 & 2026
Figure 14. By Application - Southeast Asia Drugs for Schistosomiasis Market Share, 2015-2020
Figure 15. By Application - Southeast Asia Drugs for Schistosomiasis Market Share, 2020-2026
Figure 16. By Application -Southeast Asia Drugs for Schistosomiasis Price (USD/K Units), 2015-2026
Figure 17. Southeast Asia Drugs for Schistosomiasis Production Capacity (M Units), 2015-2026
Figure 18. Southeast Asia Drugs for Schistosomiasis Actual Output (M Units), 2015-2026
Figure 19. Southeast Asia Drugs for Schistosomiasis Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of Southeast Asia Drugs for Schistosomiasis Export Destination, 2019
Figure 21. The Source of Imports of Southeast Asia Drugs for Schistosomiasis, 2019
Figure 22. PEST Analysis for Southeast Asia Drugs for Schistosomiasis Market in 2020
Figure 23. Drugs for Schistosomiasis Market Opportunities & Trends in Southeast Asia
Figure 24. Drugs for Schistosomiasis Market Drivers in Southeast Asia
Figure 25. Drugs for Schistosomiasis Market Restraints in Southeast Asia
Figure 26. Drugs for Schistosomiasis Industry Value Chain